GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Jul 29, 2026
GB Sciences Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Cash & Equivalents | 0 | 0.01 | 0.11 | 0.23 | 0.79 | 0 |
Cash & Short-Term Investments | 0 | 0.01 | 0.11 | 0.23 | 0.79 | 0 |
Cash Growth | -82.73% | -89.09% | -53.01% | -70.51% | 32860.93% | -98.68% |
Receivables | - | - | - | - | - | 5.22 |
Prepaid Expenses | 0.09 | 0.09 | 0.2 | 0.09 | 0.26 | 0.02 |
Other Current Assets | - | - | - | - | 2.49 | 1.76 |
Total Current Assets | 0.09 | 0.1 | 0.31 | 0.33 | 3.54 | 7 |
Property, Plant & Equipment | - | - | - | - | 0.03 | 0.04 |
Other Intangible Assets | - | - | 0.04 | 2.22 | 1.71 | 1.13 |
Other Long-Term Assets | - | - | - | - | 5.53 | 6.19 |
Total Assets | 0.09 | 0.1 | 0.35 | 2.55 | 10.81 | 14.35 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Accounts Payable | 2.21 | 2.01 | 1.98 | 1.66 | 1.41 | 1.91 |
Accrued Expenses | 0.71 | 0.58 | 0.42 | 0.39 | 1.45 | 1.18 |
Short-Term Debt | 1.38 | 1.38 | 1.34 | 0.93 | 3.31 | 5.44 |
Current Portion of Long-Term Debt | 0.06 | 0.06 | 0.06 | 0.05 | 0.37 | 0.36 |
Current Income Taxes Payable | 1.06 | 1.06 | 0.96 | 0.9 | 0.76 | - |
Other Current Liabilities | - | - | - | - | 1.29 | 2 |
Total Current Liabilities | 5.42 | 5.1 | 4.76 | 3.94 | 8.6 | 10.89 |
Long-Term Debt | 0.56 | 0.32 | - | 0.4 | 0.29 | - |
Other Long-Term Liabilities | - | - | - | - | 3.39 | 3.56 |
Total Liabilities | 5.97 | 5.42 | 4.76 | 4.33 | 12.28 | 14.44 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Common Stock | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 |
Additional Paid-In Capital | 104.72 | 104.71 | 104.26 | 102.76 | 102.38 | 97.27 |
Retained Earnings | -110.64 | -110.07 | -108.71 | -104.58 | -103.89 | -97.39 |
Total Common Equity | -5.88 | -5.31 | -4.41 | -1.78 | -1.47 | -0.09 |
Shareholders' Equity | -5.88 | -5.31 | -4.41 | -1.78 | -1.47 | -0.09 |
Total Liabilities & Equity | 0.09 | 0.1 | 0.35 | 2.55 | 10.81 | 14.35 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Total Debt | 1.99 | 1.76 | 1.4 | 1.38 | 3.97 | 5.79 |
Net Cash (Debt) | -1.99 | -1.75 | -1.29 | -1.15 | -3.18 | -5.79 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 |
Filing Date Shares Outstanding | 407.07 | 407.07 | 381.87 | 329.2 | 317.01 | 280.53 |
Total Common Shares Outstanding | 407.07 | 406.07 | 381.87 | 325.04 | 315.34 | 275.54 |
Working Capital | -5.32 | -4.99 | -4.45 | -3.61 | -5.05 | -3.88 |
Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 |
Tangible Book Value | -5.88 | -5.31 | -4.45 | -4 | -3.18 | -1.22 |
Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 |